Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50

Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer

(2010) R. J. Klein et al.   Cancer Prevention Research

Susceptibility Loci Associated with Prostate Cancer Progression and Mortality

(2010) D. J. Gallagher et al.   CLINICAL CANCER RESEARCH

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study

(2008) David Ulmert et al.   BMC Medicine

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

(2008) Andrew J Vickers et al.   BMC Medicine

Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population

(2008) David Ulmert et al.   JOURNAL OF CLINICAL ONCOLOGY

Reply to “Variation in KLK genes, prostate-specific antigen and risk of prostate cancer”

(2008) Rosalind Eeles et al.   NATURE GENETICS

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer

(2008) Jiyoung Ahn et al.   NATURE GENETICS

Multiple newly identified loci associated with prostate cancer susceptibility

(2008) Rosalind A Eeles et al.   NATURE GENETICS

Cumulative Association of Five Genetic Variants with Prostate Cancer

(2008) S. Lilly Zheng et al.   NEW ENGLAND JOURNAL OF MEDICINE